You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cardiovascular conditions
  5. Embolism and thrombosis

Edoxaban for preventing stroke and systemic embolism in people with non-valvular atrial fibrillation

  • Technology appraisal guidance
  • Reference number: TA355
  • Published:  23 September 2015
  • Last updated:  02 July 2021
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History
Download guidance (PDF)
  • Overview
  • 1 Recommendations
  • 2 The technology
  • 3 The company's submission
  • 4 Consideration of the evidence
  • 5 Implementation
  • 6 Appraisal Committee members, guideline representatives and NICE project team
  • 7 Sources of evidence considered by the Committee
  • Update information

Update information

July 2021: Section 1.2 updated to include the other anticoagulants approved by NICE.

ISBN: 978-1-4731-1440-1


Previous page 7 Sources of evidence considered by the Committee